Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa

Emerging Infectious Diseases

Volumn 20, Issue 3, 2014, Pages 426-433

  Gandhi, Neel R ^a,b   Brust, James C M ^a   Moodley, Prashini ^c   Weissman, Darren ^a   Heo, Moonseong ^a   Ning, Yuming ^a   Moll, Anthony P ^d,e   Friedland, Gerald H ^f   Sturm, A Willem ^c   Shah, N Sarita ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d Philanjalo ^*  (South Africa)

^e Church of Scotland Hospital   (South Africa)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; CLASSIFICATION; DRUG EFFECTS; FEMALE; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDY; SOUTH AFRICA; SURVIVAL; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADULT; ANTITUBERCULAR AGENTS; COINFECTION; FEMALE; GENETIC VARIATION; GENOTYPING TECHNIQUES; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SOUTH AFRICA; SURVIVAL ANALYSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84894271387     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2003.131083     Document Type: Article

References (40)

1. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830-43. http://dx.doi.org/10.1016/S0140-6736(10)60410-2
2. World Health Organization. Global tuberculosis report 2012. Geneva: The Organization.;2012.
3. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, et al. HIV coinfection in multidrug-and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010;181:80-6. http://dx.doi.org/10.1164/rccm.200907-0989OC
4. Wallengren K, Scano F, Nunn P, Margot B, Buthelezi SS, Williams B, et al. Drug-resistant tuberculosis, KwaZulu-Natal, South Africa, 2001-2007. Emerg Infect Dis. 2011;17:1913-6. http://dx.doi. org/10.3201/eid1710.100952
5. Pooran A, Pieterson E, Davids M, Theron G, Dheda K. What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PLoS ONE. 2013;8:e54587. http://dx.doi. org/10.1371/journal.pone.0054587
6. Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet. 2010;375:1798-807. http://dx.doi. org/10.1016/S0140-6736(10)60492-8
7. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008;359:563-74. http://dx.doi. org/10.1056/NEJMoa0800106
8. Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect Dis. 2003;3:13-21. http://dx.doi.org/10.1016/S1473-3099(03)00483-3
9. Burgos M, DeRiemer K, Small PM, Hopewell PC, Daley CL. Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis. 2003;188:1878-84. http://dx.doi.org/10.1086/379895
10. Centers for Disease Control and Prevention. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system-New York, 1991. MMWR Morb Mortal Wkly Rep. 1992;41:507-9.
11. Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-21. http://dx.doi. org/10.1056/NEJM199206043262302
12. Moro ML, Gori A, Errante I, Infuso A, Franzetti F, Sodano L, et al. An outbreak of multidrug-resistant tuberculosis involving HIVinfected patients of two hospitals in Milan, Italy. Italian Multidrug-Resistant Tuberculosis Outbreak Study Group. AIDS. 1998;12:1095-102. http://dx.doi.org/10.1097/00002030-199809000-00018
13. Coronado VG, Beck-Sague CM, Hutton MD, Davis BJ, Nicholas P, Villareal C, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis. 1993;168:1052-5. http://dx.doi.org/10.1093/infdis/168.4.1052
14. Gagneux S. Fitness cost of drug resistance in Mycobacterium tuberculosis. Clin Microbiol Infect. 2009;15(Suppl 1):66-8.
15. Johnson R, Warren RM, van der Spuy GD, Gey van Pittius NC, Theron D, Streicher EM, et al. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int J Tuberc Lung Dis. 2010;14:119-21.
16. Ioerger TR, Koo S, No EG, Chen X, Larsen MH, Jacobs WR Jr, et al. Genome analysis of multi-and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS ONE. 2009;4:e7778. http://dx.doi.org/10.1371/journal.pone.0007778
17. Gandhi NR, Weissman D, Moodley P, Ramathal M, Elson I, Kreiswirth BN, et al. Nosocomial transmission of extensively drugresistant tuberculosis in a rural hospital in South Africa. J Infect Dis. 2013;207:9-17. http://dx.doi.org/10.1093/infdis/jis631
18. Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366:2161-70. http://dx.doi.org/10.1056/NEJMoa1108789
19. Royce S, Falzon D, van Weezenbeek C, Dara M, Hyder K, Hopewell P, et al. Multidrug resistance in new tuberculosis patients: burden and implications. Int J Tuberc Lung Dis. 2013;17:511-3. http://dx.doi. org/10.5588/ijtld.12.0286
20. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis. 2008;12:99-104.
21. Stavrum R, Mphahlele M, Ovreas K, Muthivhi T, Fourie PB, Weyer K, et al. High diversity of Mycobacterium tuberculosis genotypes in South Africa and preponderance of mixed infections among ST53 isolates. J Clin Microbiol. 2009;47:1848-56. http://dx.doi.org/10.1128/JCM.02167-08
22. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002;8:843-9.
23. Hanekom M, Gey van Pittius NC, McEvoy C, Victor TC, Van Helden PD, Warren RM. Mycobacterium tuberculosis Beijing genotype: a template for success. Tuberculosis (Edinb). 2011;91:510-23. http://dx.doi.org/10.1016/j.tube.2011.07.005
24. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 2002;10:45-52. http://dx.doi.org/10.1016/S0966-842X(01)02277-6
25. Chihota VN, Muller B, Mlambo CK, Pillay M, Tait M, Streicher EM, et al. Population structure of multi-and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa. J Clin Microbiol. 2012;50:995-1002. http://dx.doi.org/10.1128/ JCM.05832-11
26. Johnson R, Warren R, Strauss OJ, Jordaan AM, Falmer AA, Beyers N, et al. An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. Int J Tuberc Lung Dis. 2006;10:1412-4.
27. Klopper M, Warren RM, Hayes C, Gey van Pittius NC, Streicher EM, Muller B, et al. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerg Infect Dis. 2013;19:449-55.
28. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575-80. http://dx.doi.org/10.1016/S0140-6736(06)69573-1
29. Pillay M, Sturm AW. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin Infect Dis. 2007;45:1409-14. http://dx.doi. org/10.1086/522987
30. Gandhi NR, Andrews JR, Brust JC, Montreuil R, Weissman D, Heo M, et al. Risk factors for mortality among MDR-and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2012;16:90-7. http://dx.doi.org/10.5588/ijtld.11.0153
31. Department of Health, Republic of South Africa. The South African National Tuberculosis Control Programme Practical Guidelines. 2004 [cited 2014 Jan 21]. http://www.kznhealth.gov.za/chrp/ documents/Guidelines/Guidelines%20National/Tuberculosis/ SA%20TB%20Guidelines%202004.pdf
32. Ashiru OT, Pillay M, Sturm AW. Adhesion to and invasion of pulmonary epithelial cells by the F15/LAM4/KZN and Beijing strains of Mycobacterium tuberculosis. J Med Microbiol. 2010;59:528-33. http://dx.doi.org/10.1099/jmm.0.016006-0
33. Ashiru OT, Pillay M, Sturm AW. Mycobacterium tuberculosis isolates grown under oxygen deprivation invade pulmonary epithelial cells. Anaerobe. 2012;18:471-4. http://dx.doi.org/10.1016/j.anaerobe. 2012.04.010
34. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006;103:2869-73. http://dx.doi.org/10.1073/pnas.0511240103
35. Basu S, Andrews JR, Poolman EM, Gandhi NR, Shah NS, Moll A, et al. Prevention of nosocomial transmission of extensively drugresistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet. 2007;370:1500-7. http://dx.doi.org/10.1016/S0140-6736(07)61636-5
36. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City-turning the tide. N Engl J Med. 1995;333:229-33. http://dx.doi.org/10.1056/NEJM199507273330406
37. Lim JR, Mthiyane T, Mlisana K, Moodley J, Ramdin N, Margot B, et al. Incidence and geographic distribution of extensively drug-resistant tuberculosis in KwaZulu-Natal Province, South Africa. [cited 2014 Jan 21]. https://idsa.confex.com/idsa/2012/ webprogram/Paper34734.html
38. Nicol MP, Wilkinson RJ. The clinical consequences of strain diversity in Mycobacterium tuberculosis. Trans R Soc Trop Med Hyg. 2008;102:955-65. http://dx.doi.org/10.1016/j.trstmh.2008.03.025
39. Click ES, Moonan PK, Winston CA, Cowan LS, Oeltmann JE. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin Infect Dis. 2012;54:211-9. http://dx.doi.org/10.1093/cid/cir788
40. Kato-Maeda M, Kim EY, Flores L, Jarlsberg LG, Osmond D, Hopewell PC. Differences among sublineages of the East-Asian lineage of Mycobacterium tuberculosis in genotypic clustering. Int J Tuberc Lung Dis. 2010;14:538-44.